KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Net Margin (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Net Margin for 7 consecutive years, with 2.79% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 61.0% to 2.79% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3.82% through Dec 2025, up 175.0% year-over-year, with the annual reading at 3.82% for FY2025, 175.0% up from the prior year.
  • Net Margin hit 2.79% in Q4 2025 for GoodRx Holdings, up from 0.57% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 30.99% in Q2 2023 to a low of 22.28% in Q3 2022.
  • Historically, Net Margin has averaged 0.47% across 5 years, with a median of 0.81% in 2021.
  • Biggest five-year swings in Net Margin: soared 18265bps in 2021 and later tumbled -2766bps in 2024.
  • Year by year, Net Margin stood at 18.72% in 2021, then surged by 94bps to 1.07% in 2022, then plummeted by -1128bps to 13.16% in 2023, then surged by 126bps to 3.39% in 2024, then dropped by -18bps to 2.79% in 2025.
  • Business Quant data shows Net Margin for GDRX at 2.79% in Q4 2025, 0.57% in Q3 2025, and 6.32% in Q2 2025.